A late-stage drug development company specialized in oncology and endocrine therapy.

Aeterna Zentaris to provide poster on AEZS-130 growth hormone secretagogue/ghrelin receptor agonist at 92nd ENDO Aeterna Zentaris Inc. , a late-stage drug development company specialized in oncology and endocrine therapy, today announced a poster on its oral synthetic growth hormones secretagogue/ghrelin receptor agonist, AEZS-130, will end up being presented at the upcoming 92nd Annual Endocrine Society Getting together with and Expo, june 19 through 22 which will be held, 2010 at the NORTH PARK Convention Center in San Diego, California.Recent research support Nemiah’s view that alexithymia and intrapsychic conflicts may both contribute to the pathogenesis of panic attacks. Addititionally there is substantial evidence of an association between childhood trauma and the development of somatic disease in adult life. Secure attachments and well-developed capacities for symbolization and have an effect on regulation appear to render individuals even more resilient to the traumas and nerve-racking events of everyday lifestyle.

Advocates, Vatican respond to Pope declaration that condom distribution will not curb HIV/Helps in Africa Pope Benedict XVI’s statement on Tuesday that condom distribution won’t curb the spread of HIV/AIDS in Africa has sparked an international outcry among HIV/Helps advocates and prompted a reply from the Vatican, AFP/Google.com reviews .